首页> 外文期刊>Journal of hepato-biliary-pancreatic sciences >Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma.
【24h】

Diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy samples of extrahepatic bile duct carcinoma.

机译:S100P和IMP3免疫组化表达在肝外胆管癌经乳头状胆钳活检中的诊断和预后价值。

获取原文
获取原文并翻译 | 示例
           

摘要

Because the biopsy specimen of extrahepatic bile duct carcinoma (EHBDC) is small and shows reactive changes, the histological distinction between malignant and benign tissue can be difficult. Recent studies reported that S100P and insulin-like growth factor II mRNA-binding protein 3 (IMP3) were not only diagnostic molecules but also prognostic biomarkers in several organs. The objective of this study is to clarify the diagnostic and prognostic value of immunohistochemical expression of S100P and IMP3 in transpapillary biliary forceps biopsy (TBFB) samples.The TBFB samples were collected from 80 patients (EHBDC, 68 patients; benign, 12 patients), retrospectively.When using cytoplasmic-positive staining for IMP3 as a marker of malignancy, the sensitivity and specificity reached 79.4 and 91.7 %, respectively. The sensitivity, specificity and accuracy achieved 89.7, 91.7 and 90.0 %, respectively, when using positive staining for IMP3 and/or positive histology as a maker of malignancy. While univariate (P = 0.033) and multivariate (P = 0.039) analysis revealed that S100P-positive EHBDC patients showed significantly shorter survival.The results of this study suggest that immunohistochemical staining for IMP3 is useful in the diagnosis of EHBDC and that of S100P is useful as a prognostic marker for EHBDC.
机译:由于肝外胆管癌(EHBDC)的活检标本很小且显示反应性变化,因此很难区分恶性和良性组织的组织学。最近的研究报道,S100P和胰岛素样生长因子II mRNA结合蛋白3(IMP3)不仅是诊断分子,而且还是一些器官的预后生物标志物。这项研究的目的是阐明S100P和IMP3的免疫组织化学表达在经乳头状胆管钳活检(TBFB)样本中的诊断和预后价值.TBFB样本来自80例患者(EHBDC,68例;良性,12例),当使用细胞质阳性染色的IMP3作为恶性肿瘤的标志物时,敏感性和特异性分别达到79.4%和91.7%。当使用IMP3阳性染色和/或阳性组织学作为恶性肿瘤的产生者时,敏感性,特异性和准确性分别达到89.7%,91.7%和90.0%。单因素(P = 0.033)和多因素(P = 0.039)分析显示S100P阳性的EHBDC患者的生存期明显缩短。这项研究的结果表明IMP3的免疫组织化学染色可用于EHBDC的诊断,而S100P的免疫组化可用于可用作EHBDC的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号